SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

MRK1

135.5

-0.7%↓

PHIA

24.26

+0.96%↑

FRE

36.5

+0.25%↑

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

MRK1

135.5

-0.7%↓

PHIA

24.26

+0.96%↑

FRE

36.5

+0.25%↑

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

MRK1

135.5

-0.7%↓

PHIA

24.26

+0.96%↑

FRE

36.5

+0.25%↑

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

MRK1

135.5

-0.7%↓

PHIA

24.26

+0.96%↑

FRE

36.5

+0.25%↑

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

MRK1

135.5

-0.7%↓

PHIA

24.26

+0.96%↑

FRE

36.5

+0.25%↑

Search

Faes Farma SA

Closed

3.72 1.36

Overview

Share price change

24h

Current

Min

3.72

Max

3.73

Key metrics

By Trading Economics

Income

28M

58M

Sales

-4.4M

135M

P/E

Sector Avg

12.233

73.394

Dividend yield

2.23

Profit margin

43.344

Employees

1,748

EBITDA

2.7M

43M

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.23%

3.09%

Next Earnings

28 Feb 2025

Market Stats

By TradingEconomics

Market Cap

1.1B

Previous open

2.36

Previous close

3.72

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Faes Farma SA Chart

Past performance is not a reliable indicator of future results.

Related News

22 Feb 2025, 00:16 UTC

Hot Stocks

Stocks to Watch: Alamos Gold, Booking Holdings

22 Feb 2025, 16:33 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 15:15 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 14:32 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:49 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

22 Feb 2025, 13:22 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Earnings Rose 71% to $14.5 Billion in Fourth Quarter -- Barrons.com

21 Feb 2025, 23:22 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- Update

21 Feb 2025, 23:20 UTC

Earnings

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

21 Feb 2025, 22:34 UTC

Market Talk

L'Oréal Cuts Exposure to Chinese Market, Grows Emerging Markets -- Market Talk

21 Feb 2025, 22:12 UTC

Top News

DOJ Investigates Medicare Billing Practices at UnitedHealth -- 2nd Update

21 Feb 2025, 21:54 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- 2nd Update

21 Feb 2025, 21:51 UTC

Earnings

Tesla Stock Falls. Recalls and Rivian Are in the News. -- Barrons.com

21 Feb 2025, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

21 Feb 2025, 21:50 UTC

Top News

DOGE Aide's IRS Access Won't Include Personal Information -- WSJ

21 Feb 2025, 21:48 UTC

Market Talk
Earnings

L'Oréal Tops Estée Lauder in Luxury U.S. Market, CEO Says -- Market Talk

21 Feb 2025, 21:35 UTC

Market Talk

Bulk of U.S. Imports From Canada Used to Make U.S. Goods -- Market Talk

21 Feb 2025, 21:28 UTC

Top News

Why Is Warren Buffett Hoarding So Much Cash? -- Update

21 Feb 2025, 21:24 UTC

Top News

Major U.S. Stock Indexes Give Up Gains From the Week -- WSJ

21 Feb 2025, 21:19 UTC

Market Talk

Mexico's Inflation Seen Up in Early February -- Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

Global Equities Roundup: Market Talk

21 Feb 2025, 20:15 UTC

Market Talk

JPMorgan Chase Branch Expansion Portends Deposit Growth -- Market Talk

21 Feb 2025, 20:05 UTC

Market Talk

Oil Futures Retreat Into the Weekend Again -- Market Talk

21 Feb 2025, 19:58 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Gain -- Market Talk

21 Feb 2025, 19:29 UTC

Market Talk

Gold Slides After Finding Record High -- Market Talk

21 Feb 2025, 19:26 UTC

Top News

Major U.S. Stock Indexes Slip; UnitedHealth Pulls Down DJIA -- WSJ

21 Feb 2025, 19:05 UTC

Market Talk

Business Conditions Seen as Favoring Corporate Credit -- Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

21 Feb 2025, 19:02 UTC

Market Talk

Corporate Credit Expected to Be Hit Unevenly by Trade Wars -- Market Talk

21 Feb 2025, 19:00 UTC

Market Talk

Long-Term Treasury Yields Expected to Rise -- Market Talk

Peer Comparison

Price change

Faes Farma SA Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

3.685 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Faes Farma SA

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.